C. Tallant

3.7k citations

34 papers · 2.1k indexed · h-index 23

Co-authors: F. Xavier Gomis‐Rüth Aniebrys Marrero Stefan Knapp Susanne Müller Paul E. Brennan Catherine Rogers Octovia Monteiro O. Fedorov
Topics: Protein Degradation and Inhibitors (25 papers)Multiple Myeloma Research and Treatments (18 papers)Histone Deacetylase Inhibitors Research (7 papers)
Cited by: Hematology Molecular Biology Cancer Research
Journals: Science Proceedings of the National Academy of Sciences Journal of the American Chemical Society
Partner nations: United Kingdom United States Germany

In The Last Decade

C. Tallant

34 papers receiving 2.1k citations

Peers

Countries citing papers authored by C. Tallant

Since Specialization

Citations

This map shows the geographic impact of C. Tallant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Tallant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Tallant more than expected).

Fields of papers citing papers by C. Tallant

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Tallant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Tallant. The network helps show where C. Tallant may publish in the future.

Co-authorship network of co-authors of C. Tallant

This figure shows the co-authorship network connecting the top 25 collaborators of C. Tallant. A scholar is included among the top collaborators of C. Tallant based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Tallant. C. Tallant is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Identification of Histone Peptide Binding Specificity and Small-Molecule Ligands for the TRIM33α and TRIM33β Bromodomains 2022 ·ACS Chemical Biology ·(unknown),(unknown),(unknown),(unknown),(unknown),C. Tallant,(unknown),Katarzyna B. Leszczyńska,Rachel L. Grimley,Richard Storer,(unknown),(unknown),Sofia Caria,(unknown),Ester M. Hammond,Stefan Knapp,Garrett M. Morris,Fernanda Duarte,Philip C. Biggin,Stuart J. Conway	13
2	Expanding Bromodomain Targeting into Neglected Parasitic Diseases 2021 ·ACS Infectious Diseases ·C. Tallant,Paul Bamborough,Chun‐wa Chung,Francisco‐Javier Gamo,Robert B. Kirkpatrick,(unknown),Julio Martín,Rab K. Prinjha,Inmaculada Rioja,Daniel F. Simola,(unknown),Félix Calderón	13
3	Conformational plasticity of the ULK3 kinase domain 2021 ·Biochemical Journal ·Sebastian Mathea,E. Salah,C. Tallant,Deep Chatterjee,Benedict‐Tilman Berger,Rebecca Konietzny,Susanne Müller,Benedikt M. Kessler,Stefan Knapp	9
4	Identifying Small‐Molecule Binding Sites for Epigenetic Proteins at Domain–Domain Interfaces 2018 ·ChemMedChem ·(unknown),R. Talon,C. Tallant,Chris Schofield,(unknown),Stefan Knapp,Gordon Bruton,Paul E. Brennan	11
5	An Activity‐Based Probe Targeting Non‐Catalytic, Highly Conserved Amino Acid Residues within Bromodomains 2018 ·Angewandte Chemie International Edition ·Melissa D’Ascenzio,(unknown),Rebecca Konietzny,G. Berridge,C. Tallant,(unknown),Octovia Monteiro,Jason R. Thomas,Markus Schirle,Stefan Knapp,Brian D. Marsden,Oleg Fedorov,C. Bountra,Benedikt M. Kessler,Paul E. Brennan	19
6	Exploiting a water network to achieve enthalpy-driven, bromodomain-selective BET inhibitors 2017 ·Bioorganic & Medicinal Chemistry ·William R. Shadrick,P.J. Slavish,Sergio C. Chai,(unknown),Michele Connelly,Jonathan Low,C. Tallant,Brandon Young,Nagakumar Bharatham,Stefan Knapp,Vincent A. Boyd,Marie Morfouace,Martine F. Roussel,Taosheng Chen,Richard Lee,R. Kiplin Guy,Anang A. Shelat,Philip M. Potter	21
7	Effect of BET Missense Mutations on Bromodomain Function, Inhibitor Binding and Stability 2016 ·PLoS ONE ·(unknown),Alessandra Pasquo,(unknown),Maria Petrosino,Roberta Chiaraluce,C. Tallant,Stefan Knapp,Valerio Consalvi	15
8	Mapping the chemical chromatin reactivation landscape identifies BRD4-TAF1 cross-talk 2016 ·Nature Chemical Biology ·Sara Sdelci,Charles-Hugues Lardeau,C. Tallant,Freya Klepsch,(unknown),James M. Bennett,Philipp Rathert,Michael Schuster,Thomas Penz,O. Fedorov,Giulio Superti‐Furga,Christoph Bock,Johannes Zuber,K. Huber,Stefan Knapp,Susanne Müller,Stefan Kubicek	33
9	CBP30, a selective CBP/p300 bromodomain inhibitor, suppresses human Th17 responses 2015 ·Proceedings of the National Academy of Sciences ·Ariane Hammitzsch,C. Tallant,O. Fedorov,Alison O’Mahony,Paul E. Brennan,Duncan A. Hay,Fernando O. Martínez,Hussein Al‐Mossawi,Jelle de Wit,Matteo Vecellio,Christopher Wells,B P Wordsworth,Susanne Müller,Stefan Knapp,Paul Bowness	195
10	LP99: Discovery and Synthesis of the First Selective BRD7/9 Bromodomain Inhibitor 2015 ·Angewandte Chemie ·Peter G. K. Clark,Lucas Campos Curcino Vieira,C. Tallant,O. Fedorov,Dean C. Singleton,Catherine Rogers,Octovia Monteiro,James M. Bennett,Roberta Baronio,Susanne Müller,Danette L. Daniels,Jacqui Méndez,Stefan Knapp,Paul E. Brennan,Darren J. Dixon	111
11	LP99: Discovery and Synthesis of the First Selective BRD7/9 Bromodomain Inhibitor 2015 ·Angewandte Chemie International Edition ·Peter G. K. Clark,Lucas Campos Curcino Vieira,C. Tallant,O. Fedorov,Dean C. Singleton,Catherine Rogers,Octovia Monteiro,James M. Bennett,Roberta Baronio,Susanne Müller,Danette L. Daniels,Jacqui Méndez,Stefan Knapp,Paul E. Brennan,Darren J. Dixon	134
12	Identification of Covalent Bromodomain Binders through DNA Display of Small Molecules 2015 ·Angewandte Chemie International Edition ·Jean‐Pierre Daguer,Claudio Zambaldo,Daniel Abegg,Sofía Barluenga,C. Tallant,Susanne Müller,Alexander Adibekian,Nicolas Winssinger	54
13	New Synthetic Routes to Triazolo-benzodiazepine Analogues: Expanding the Scope of the Bump-and-Hole Approach for Selective Bromo and Extra-Terminal (BET) Bromodomain Inhibition 2015 ·Journal of Medicinal Chemistry ·Matthias G. J. Baud,Enrique Lin-Shiao,Michael Zengerle,C. Tallant,Alessio Ciulli	38
14	Molecular Basis of Histone Tail Recognition by Human TIP5 PHD Finger and Bromodomain of the Chromatin Remodeling Complex NoRC 2014 ·Structure ·C. Tallant,Erica Valentini,O. Fedorov,(unknown),Fleur M. Ferguson,P. Filippakopoulos,Dmitri I. Svergun,Stefan Knapp,Alessio Ciulli	55
15	A Bacillus anthracis strain deleted for six proteases serves as an effective host for production of recombinant proteins 2011 ·Protein Expression and Purification ·Andrei P. Pomerantsev,(unknown),Mahtab Moayeri,Rasem Fattah,C. Tallant,Stephen H. Leppla	43
16	On the Relevance of the Met-turn Methionine in Metzincins 2010 ·Journal of Biological Chemistry ·C. Tallant,Raquel García-Castellanos,Ulrich Baumann,F. Xavier Gomis‐Rüth	36
17	Unique Structure and Stability of HmuY, a Novel Heme-Binding Protein of Porphyromonas gingivalis 2009 ·PLoS Pathogens ·Halina Wójtowicz,Tibisay Guevara,C. Tallant,Mariusz Olczak,Aneta Sroka,Jan Potempa,Marı́a Solà,Teresa Olczak,F. Xavier Gomis‐Rüth	88
18	Matrix metalloproteinases: Fold and function of their catalytic domains 2009 ·Biochimica et Biophysica Acta (BBA) - Molecular Cell Research ·C. Tallant,Aniebrys Marrero,F. Xavier Gomis‐Rüth	348
19	Activity of ulilysin, an archaeal PAPP-A-related gelatinase and IGFBP protease 2007 ·Biological Chemistry ·C. Tallant,Raquel García-Castellanos,Aniebrys Marrero,Françesc Canals,(unknown),Jean‐Louis Reymond,Marı́a Solà,Ulrich Baumann,F. Xavier Gomis‐Rüth	11
20	Molecular Analysis of Ulilysin, the Structural Prototype of a New Family of Metzincin Metalloproteases 2006 ·Journal of Biological Chemistry ·C. Tallant,Raquel García-Castellanos,(unknown),Ulrich Baumann,F. Xavier Gomis‐Rüth	60

About C. Tallant

C. Tallant is a scholar working on Hematology, Virology and Molecular Biology, having authored 34 papers that have together received 2.1k indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (25 papers), Multiple Myeloma Research and Treatments (18 papers) and Histone Deacetylase Inhibitors Research (7 papers). The work is most often cited by research in Hematology (560 citations), Molecular Biology (1.6k citations) and Cancer Research (281 citations). C. Tallant has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include F. Xavier Gomis‐Rüth, Aniebrys Marrero, Stefan Knapp, Susanne Müller, Paul E. Brennan, Catherine Rogers, Octovia Monteiro, O. Fedorov, Oleg Fedorov and Duncan A. Hay. Their work appears in journals such as Science, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact